DPP-4抑制剂-话题@MedSci

#DPP-4抑制剂#

44篇内容 | 2456人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1374118, encodeId=6fc713e4118c8, content=<a href='/topic/show?id=dad4621545' target=_blank style='color:#2F92EE;'>#DPP-4抑制剂#</a>, objectTitle=DIABETOLOGIA：DPP-4抑制剂利格列汀抗血管生成作用是通过抑制氧诱导视网膜病变小鼠模型中VEGFR信号通路实现的？, objectType=article, longId=156533, objectId=8846156533e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8846156533e5, replyNumber=0, likeNumber=61, createdTime=2018-12-25, rootId=0, userName=ewsr1, userId=a8d7373, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8846156533e5, moduleTitle=DIABETOLOGIA：DPP-4抑制剂利格列汀抗血管生成作用是通过抑制氧诱导视网膜病变小鼠模型中VEGFR信号通路实现的？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8846156533e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374117, encodeId=1e7513e41170d, content=<a href='/topic/show?id=dad4621545' target=_blank style='color:#2F92EE;'>#DPP-4抑制剂#</a>, objectTitle=BMJ：DPP-4抑制剂以及GLP-1激动剂或导致糖尿病患者胆管癌风险增加, objectType=article, longId=155614, objectId=db9d15561414, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db9d15561414, replyNumber=0, likeNumber=44, createdTime=2018-12-13, rootId=0, userName=ewsr1, userId=a8d7373, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db9d15561414, moduleTitle=BMJ：DPP-4抑制剂以及GLP-1激动剂或导致糖尿病患者胆管癌风险增加, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=db9d15561414)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374116, encodeId=051f13e4116bc, content=<a href='/topic/show?id=dad4621545' target=_blank style='color:#2F92EE;'>#DPP-4抑制剂#</a>, objectTitle=Int Immunopharmacol：在体外培养中DPP-4抑制剂对视网膜内皮细胞具有保护作用, objectType=article, longId=155570, objectId=3d4d1555e01e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d4d1555e01e, replyNumber=0, likeNumber=56, createdTime=2018-12-12, rootId=0, userName=ewsr1, userId=a8d7373, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d4d1555e01e, moduleTitle=Int Immunopharmacol：在体外培养中DPP-4抑制剂对视网膜内皮细胞具有保护作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d4d1555e01e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374115, encodeId=777313e41153a, content=<a href='/topic/show?id=dad4621545' target=_blank style='color:#2F92EE;'>#DPP-4抑制剂#</a>, objectTitle=Diabetes：经典降糖药DPP-4抑制剂竟然还是糖尿病足的克星, objectType=article, longId=125868, objectId=eb8e12586871, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb8e12586871, replyNumber=0, likeNumber=73, createdTime=2018-01-09, rootId=0, userName=ewsr1, userId=a8d7373, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb8e12586871, moduleTitle=Diabetes：经典降糖药DPP-4抑制剂竟然还是糖尿病足的克星, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eb8e12586871)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374114, encodeId=5be413e41141c, content=<a href='/topic/show?id=dad4621545' target=_blank style='color:#2F92EE;'>#DPP-4抑制剂#</a>, objectTitle=Diabetes Care：“调解官”二甲双胍能改善DPP-4抑制剂对心血管的影响？, objectType=article, longId=124730, objectId=d2be124e3032, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d2be124e3032, replyNumber=0, likeNumber=60, createdTime=2017-12-28, rootId=0, userName=ewsr1, userId=a8d7373, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d2be124e3032, moduleTitle=Diabetes Care：“调解官”二甲双胍能改善DPP-4抑制剂对心血管的影响？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d2be124e3032)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374113, encodeId=354213e4113d1, content=<a href='/topic/show?id=dad4621545' target=_blank style='color:#2F92EE;'>#DPP-4抑制剂#</a>, objectTitle=Diabetes Obes Metab：DPP-4抑制剂不对β细胞功能造成影响, objectType=article, longId=124210, objectId=44971242109d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=44971242109d, replyNumber=0, likeNumber=104, createdTime=2017-12-23, rootId=0, userName=ewsr1, userId=a8d7373, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=44971242109d, moduleTitle=Diabetes Obes Metab：DPP-4抑制剂不对β细胞功能造成影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=44971242109d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374112, encodeId=330a13e41120e, content=<a href='/topic/show?id=dad4621545' target=_blank style='color:#2F92EE;'>#DPP-4抑制剂#</a>, objectTitle=Diabetes Care：二甲双胍或可调节DPP-4抑制剂对心血管结局的影响。, objectType=article, longId=117983, objectId=dbcf11e98358, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dbcf11e98358, replyNumber=0, likeNumber=67, createdTime=2017-10-30, rootId=0, userName=ewsr1, userId=a8d7373, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dbcf11e98358, moduleTitle=Diabetes Care：二甲双胍或可调节DPP-4抑制剂对心血管结局的影响。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dbcf11e98358)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374111, encodeId=75ba13e41111e, content=<a href='/topic/show?id=dad4621545' target=_blank style='color:#2F92EE;'>#DPP-4抑制剂#</a>, objectTitle=Diabetes Obes Metab：DPP-4抑制剂和SU治疗的HHF风险无组内差异, objectType=article, longId=117597, objectId=6cd411e59781, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6cd411e59781, replyNumber=0, likeNumber=82, createdTime=2017-10-27, rootId=0, userName=ewsr1, userId=a8d7373, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6cd411e59781, moduleTitle=Diabetes Obes Metab：DPP-4抑制剂和SU治疗的HHF风险无组内差异, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6cd411e59781)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374110, encodeId=f12613e41104a, content=<a href='/topic/show?id=dad4621545' target=_blank style='color:#2F92EE;'>#DPP-4抑制剂#</a>, objectTitle=Circulation：GLP-1受体激动剂和DPP-4抑制剂的心血管作用和临床结局, objectType=article, longId=115971, objectId=da471159e1cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=da471159e1cb, replyNumber=0, likeNumber=80, createdTime=2017-10-14, rootId=0, userName=ewsr1, userId=a8d7373, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=da471159e1cb, moduleTitle=Circulation：GLP-1受体激动剂和DPP-4抑制剂的心血管作用和临床结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=da471159e1cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374109, encodeId=f98713e4109a1, content=<a href='/topic/show?id=dad4621545' target=_blank style='color:#2F92EE;'>#DPP-4抑制剂#</a>, objectTitle=JAHA:DPP-4抑制剂阿拉格列丁能够抑制颅内动脉瘤的形成, objectType=article, longId=102909, objectId=ac111029097a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ac111029097a, replyNumber=0, likeNumber=63, createdTime=2017-06-23, rootId=0, userName=ewsr1, userId=a8d7373, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ac111029097a, moduleTitle=JAHA:DPP-4抑制剂阿拉格列丁能够抑制颅内动脉瘤的形成, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ac111029097a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374108, encodeId=1bad13e41088b, content=<a href='/topic/show?id=dad4621545' target=_blank style='color:#2F92EE;'>#DPP-4抑制剂#</a>, objectTitle=DPP-4抑制剂治疗降低T2DM患者外周动脉疾病和下肢截肢风险, objectType=article, longId=87342, objectId=9ade8e342f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ade8e342f5, replyNumber=0, likeNumber=69, createdTime=2017-01-13, rootId=0, userName=ewsr1, userId=a8d7373, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ade8e342f5, moduleTitle=DPP-4抑制剂治疗降低T2DM患者外周动脉疾病和下肢截肢风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9ade8e342f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374107, encodeId=112c13e4107f0, content=<a href='/topic/show?id=dad4621545' target=_blank style='color:#2F92EE;'>#DPP-4抑制剂#</a>, objectTitle=造福老年2型糖尿病人群，DPP-4抑制剂西格列汀让更多患者受益, objectType=article, longId=86450, objectId=3a6086450fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a6086450fa, replyNumber=0, likeNumber=71, createdTime=2017-01-05, rootId=0, userName=ewsr1, userId=a8d7373, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a6086450fa, moduleTitle=造福老年2型糖尿病人群，DPP-4抑制剂西格列汀让更多患者受益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3a6086450fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374106, encodeId=a16d13e410602, content=<a href='/topic/show?id=dad4621545' target=_blank style='color:#2F92EE;'>#DPP-4抑制剂#</a>, objectTitle=DPP-4抑制剂多重获益，助力中国2型糖尿病管理, objectType=article, longId=83314, objectId=68c383314af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=68c383314af, replyNumber=0, likeNumber=65, createdTime=2016-12-01, rootId=0, userName=ewsr1, userId=a8d7373, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=68c383314af, moduleTitle=DPP-4抑制剂多重获益，助力中国2型糖尿病管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=68c383314af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374105, encodeId=3f4413e410542, content=<a href='/topic/show?id=dad4621545' target=_blank style='color:#2F92EE;'>#DPP-4抑制剂#</a>, objectTitle=Heart：使用DPP-4抑制剂可降低心血管事件发生的风险, objectType=article, longId=81562, objectId=615781562ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=615781562ab, replyNumber=0, likeNumber=61, createdTime=2016-11-02, rootId=0, userName=ewsr1, userId=a8d7373, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=615781562ab, moduleTitle=Heart：使用DPP-4抑制剂可降低心血管事件发生的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=615781562ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374104, encodeId=e09013e410479, content=<a href='/topic/show?id=dad4621545' target=_blank style='color:#2F92EE;'>#DPP-4抑制剂#</a>, objectTitle=BMJ：DPP-4抑制剂加磺酰脲类药物与低血糖风险, objectType=article, longId=67469, objectId=36856e46917, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=36856e46917, replyNumber=0, likeNumber=45, createdTime=2016-05-05, rootId=0, userName=智慧医人, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=36856e46917, moduleTitle=BMJ：DPP-4抑制剂加磺酰脲类药物与低血糖风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=36856e46917)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374103, encodeId=335013e4103ca, content=<a href='/topic/show?id=dad4621545' target=_blank style='color:#2F92EE;'>#DPP-4抑制剂#</a>, objectTitle=CDS 2015：洪天配解读DPP-4抑制剂与SGLT-2抑制剂在糖尿病治疗中的协同作用, objectType=article, longId=60556, objectId=f8216055671, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8216055671, replyNumber=0, likeNumber=45, createdTime=2015-12-14, rootId=0, userName=ewsr1, userId=a8d7373, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8216055671, moduleTitle=CDS 2015：洪天配解读DPP-4抑制剂与SGLT-2抑制剂在糖尿病治疗中的协同作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f8216055671)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374102, encodeId=821613e41020b, content=<a href='/topic/show?id=dad4621545' target=_blank style='color:#2F92EE;'>#DPP-4抑制剂#</a>, objectTitle=AIM：DPP-4抑制剂治疗T2DM心衰患者可将风险降到很低, objectType=article, longId=57839, objectId=c59a5e83922, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c59a5e83922, replyNumber=0, likeNumber=74, createdTime=2015-10-28, rootId=0, userName=ewsr1, userId=a8d7373, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c59a5e83922, moduleTitle=AIM：DPP-4抑制剂治疗T2DM心衰患者可将风险降到很低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c59a5e83922)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374101, encodeId=7ff913e4101a6, content=<a href='/topic/show?id=dad4621545' target=_blank style='color:#2F92EE;'>#DPP-4抑制剂#</a>, objectTitle=ADA 2015：DPP-4抑制剂西格列汀心血管安全性良好（TECOS研究）, objectType=article, longId=51869, objectId=15cd51869b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=15cd51869b4, replyNumber=0, likeNumber=68, createdTime=2015-06-11, rootId=0, userName=ewsr1, userId=a8d7373, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=15cd51869b4, moduleTitle=ADA 2015：DPP-4抑制剂西格列汀心血管安全性良好（TECOS研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=15cd51869b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374100, encodeId=560413e410081, content=<a href='/topic/show?id=dad4621545' target=_blank style='color:#2F92EE;'>#DPP-4抑制剂#</a>, objectTitle=Diabetologia：DPP-4抑制剂可通过GIP-胰高血糖素负反馈轴阻止低血糖发生, objectType=article, longId=49858, objectId=d38d4985820, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d38d4985820, replyNumber=0, likeNumber=54, createdTime=2015-04-26, rootId=0, userName=ewsr1, userId=a8d7373, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d38d4985820, moduleTitle=Diabetologia：DPP-4抑制剂可通过GIP-胰高血糖素负反馈轴阻止低血糖发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d38d4985820)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374099, encodeId=147713e4099c1, content=<a href='/topic/show?id=dad4621545' target=_blank style='color:#2F92EE;'>#DPP-4抑制剂#</a>, objectTitle=合并心衰的2型糖尿病患者还能用DPP-4抑制剂吗, objectType=article, longId=29669, objectId=5e1f2966944, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e1f2966944, replyNumber=0, likeNumber=65, createdTime=2014-01-22, rootId=0, userName=ewsr1, userId=a8d7373, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e1f2966944, moduleTitle=合并心衰的2型糖尿病患者还能用DPP-4抑制剂吗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5e1f2966944)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

DPP-4抑制剂

2020-05-29

ewsr1 (审核中...)

前往app查看评论内容

#DPP-4抑制剂#

DIABETOLOGIA：DPP-4抑制剂利格列汀抗血管生成作用是通过抑制氧诱导视网膜病变小鼠模型中VEGFR信号通路实现的？

2018-12-25

ewsr1 (审核中...)

前往app查看评论内容

#DPP-4抑制剂#

BMJ：DPP-4抑制剂以及GLP-1激动剂或导致糖尿病患者胆管癌风险增加

2018-12-13

ewsr1 (审核中...)

前往app查看评论内容

#DPP-4抑制剂#

Int Immunopharmacol：在体外培养中DPP-4抑制剂对视网膜内皮细胞具有保护作用

2018-12-12

ewsr1 (审核中...)

前往app查看评论内容

#DPP-4抑制剂#

Diabetes：经典降糖药DPP-4抑制剂竟然还是糖尿病足的克星

2018-01-09

ewsr1 (审核中...)

前往app查看评论内容

#DPP-4抑制剂#

Diabetes Care：“调解官”二甲双胍能改善DPP-4抑制剂对心血管的影响？

2017-12-28

ewsr1 (审核中...)

前往app查看评论内容

#DPP-4抑制剂#

Diabetes Obes Metab：DPP-4抑制剂不对β细胞功能造成影响

2017-12-23

ewsr1 (审核中...)

前往app查看评论内容

#DPP-4抑制剂#

Diabetes Care：二甲双胍或可调节DPP-4抑制剂对心血管结局的影响。

2017-10-30

ewsr1 (审核中...)

前往app查看评论内容

#DPP-4抑制剂#

Diabetes Obes Metab：DPP-4抑制剂和SU治疗的HHF风险无组内差异

2017-10-27

ewsr1 (审核中...)

前往app查看评论内容

#DPP-4抑制剂#

Circulation：GLP-1受体激动剂和DPP-4抑制剂的心血管作用和临床结局

2017-10-14

ewsr1 (审核中...)

前往app查看评论内容

#DPP-4抑制剂#

JAHA:DPP-4抑制剂阿拉格列丁能够抑制颅内动脉瘤的形成

2017-06-23

ewsr1 (审核中...)

前往app查看评论内容

#DPP-4抑制剂#

DPP-4抑制剂治疗降低T2DM患者外周动脉疾病和下肢截肢风险

2017-01-13

ewsr1 (审核中...)

前往app查看评论内容

#DPP-4抑制剂#

造福老年2型糖尿病人群，DPP-4抑制剂西格列汀让更多患者受益

2017-01-05

ewsr1 (审核中...)

前往app查看评论内容

#DPP-4抑制剂#

DPP-4抑制剂多重获益，助力中国2型糖尿病管理

2016-12-01

ewsr1 (审核中...)

前往app查看评论内容

#DPP-4抑制剂#

Heart：使用DPP-4抑制剂可降低心血管事件发生的风险

2016-11-02

智慧医人 (审核中...)

前往app查看评论内容

#DPP-4抑制剂#

BMJ：DPP-4抑制剂加磺酰脲类药物与低血糖风险

2016-05-05

ewsr1 (审核中...)

前往app查看评论内容

#DPP-4抑制剂#

CDS 2015：洪天配解读DPP-4抑制剂与SGLT-2抑制剂在糖尿病治疗中的协同作用

2015-12-14

ewsr1 (审核中...)

前往app查看评论内容

#DPP-4抑制剂#

AIM：DPP-4抑制剂治疗T2DM心衰患者可将风险降到很低

2015-10-28

ewsr1 (审核中...)

前往app查看评论内容

#DPP-4抑制剂#

ADA 2015：DPP-4抑制剂西格列汀心血管安全性良好（TECOS研究）

2015-06-11

ewsr1 (审核中...)

前往app查看评论内容

#DPP-4抑制剂#

Diabetologia：DPP-4抑制剂可通过GIP-胰高血糖素负反馈轴阻止低血糖发生

2015-04-26

ewsr1 (审核中...)

前往app查看评论内容

#DPP-4抑制剂#

合并心衰的2型糖尿病患者还能用DPP-4抑制剂吗

2014-01-22

科室
- - 订阅+
  - 更多科室
工具
服务